Category: Global Blogs

Italy: Health regs want $2B from pharma giants’ repeated antitrust violations (Competition Policy International)

Italy’s health regulator is reportedly seeking damages worth nearly$2 billion from three of the world’s largest pharmaceutical firms for their repeated antitrust violations and subsequent harm on the nation’s health industry.

According to reports, the nation’s health ministry announced Wednesday it is seeking about $1.6 billion in damages from Novartis and …read more

EU: Why Facebook wants EC to probe WhatsApp buy (Competition Policy International)

Facebook has reportedly requested a full investigation into its proposed acquisition of messaging application WhatsApp by the European Commission, according to reports.

The social media giant wants the Commission to review the $19 billion merger in hopes of bypassing several investigations by national EU competition regulators. Reports say Facebook is concerned …read more

US: DOJ urged to redirect attention to Amazon’s hostility against publishers (Competition Policy International)

The US Department of Justice has reportedly responded to Apple’s appeal of last year’s verdict that found Apple collude to fix eBook prices, but some experts are wondering whether the DOJ should be more concerned with Amazon and its treatment of eBook publishers.

According to reports, the DOJ filed a 117-page …read more

FTC v. Actavis on Remand: A New Chapter (Sheppard Mullin Antitrust Connect Blog)

District Court refuses to grant renewed motion to dismiss based on Noerr-Pennington doctrine. In re AndroGel Antitrust Litigation (No. II), MDL No. 2084 (re Federal Trade Commission v. Actavis, Inc., No. 1:09-CV-955-TWT) (N.D. GA April 21, 2014).

In April 1999, Solvay Pharmaceuticals, LLC (“Solvay”) filed a New Drug Application (“NDA”) …read more